If you liked this article you might like

Morning Movers: BUD, VZ, CELG, GS

Morning Movers: BUD, VZ, CELG, GS

Celgene Can't Expand Revlimid Approval Into Non-Hodgkin Lymphoma Just Yet

Celgene Can't Expand Revlimid Approval Into Non-Hodgkin Lymphoma Just Yet

Bullish and Bearish Reversals for the Week

Bullish and Bearish Reversals for the Week

Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week

Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week